Peripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy of CART19 in Refractory or Relapsed B-ALL

0
99
Scientists retrospectively analyzed 143 patients treated with CART19 to evaluate the effect of peripheral leukemia burden at time of apheresis.
[Molecular Therapy-Methods & Clinical Development]
AbstractFull ArticleGraphical Abstract